Tremelimumab (anti-CTLA-4)

Catalog No.A2021 Synonyms: Ticilimumab, CP-675,206

For research use only.
Not for use in humans.

Tremelimumab (Ticilimumab, CP-675,206) is a fully human monoclonal antibody that binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on the surface of activated T lymphocytes.

Tremelimumab (anti-CTLA-4)

Purity & Quality Control

Choose Selective CD markers Inhibitors

Biological Activity

Description Tremelimumab (Ticilimumab, CP-675,206) is a fully human monoclonal antibody that binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on the surface of activated T lymphocytes.

Protocol (from reference)

Product Details

CAS No. 745013-59-6
Molecular Weight 146.4 kDa
Formulation PBS Buffer, PH 7.4
Isotype Human IgG2
Source HEK293 Cells
Storage Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Purification Protein G
Sterility 0.2 μM filtered

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Tremelimumab (anti-CTLA-4) | Tremelimumab (anti-CTLA-4) supplier | purchase Tremelimumab (anti-CTLA-4) | Tremelimumab (anti-CTLA-4) cost | Tremelimumab (anti-CTLA-4) manufacturer | order Tremelimumab (anti-CTLA-4) | Tremelimumab (anti-CTLA-4) distributor